Journal article
1956P Osimertinib then chemotherapy in EGFR-mutated lung cancer with osimertinib third-line rechallenge (OCELOT-cohort A interim analysis)
Authors
Vincent MD; Menjak I; Wheatley-Price P; Liu G; Khan SR; Laskin J; Rothenstein J; Salinas MV; Bains P; Cheema PK
Journal
Annals of Oncology, Vol. 36, ,
Publisher
Elsevier
Publication Date
September 1, 2025
DOI
10.1016/j.annonc.2025.08.2580
ISSN
0923-7534